|
ZA836080B
(en)
*
|
1982-08-23 |
1984-04-25 |
Scripps Clinic Res |
Broad spectrum influenza antisera
|
|
US5182192A
(en)
|
1987-03-27 |
1993-01-26 |
The Wistar Institute |
Monoclonal antibodies against glycolipid antigens, methods of producing these antibodies, and use therefor
|
|
US6001634A
(en)
|
1989-08-28 |
1999-12-14 |
Palese; Peter |
Recombinant negative strand RNA viruses
|
|
US5854037A
(en)
|
1989-08-28 |
1998-12-29 |
The Mount Sinai School Of Medicine Of The City University Of New York |
Recombinant negative strand RNA virus expression systems and vaccines
|
|
US6887699B1
(en)
|
1990-05-22 |
2005-05-03 |
Medimmune Vaccines, Inc. |
Recombinant negative strand RNA virus expression systems and vaccines
|
|
GB9015198D0
(en)
|
1990-07-10 |
1990-08-29 |
Brien Caroline J O |
Binding substance
|
|
FR2664905B1
(fr)
|
1990-07-18 |
1994-08-12 |
Agronomique Inst Nat Rech |
Baculovirus modifie, son procede d'obtention, et vecteurs d'expression obtenus a partir dudit baculovirus.
|
|
US5661016A
(en)
|
1990-08-29 |
1997-08-26 |
Genpharm International Inc. |
Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
|
|
US5625126A
(en)
|
1990-08-29 |
1997-04-29 |
Genpharm International, Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
|
US5633425A
(en)
|
1990-08-29 |
1997-05-27 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
|
DE69127627T2
(de)
|
1990-08-29 |
1998-02-19 |
Genpharm Int |
Produktion und Nützung nicht-menschliche transgentiere zur Produktion heterologe Antikörper
|
|
US5545806A
(en)
|
1990-08-29 |
1996-08-13 |
Genpharm International, Inc. |
Ransgenic non-human animals for producing heterologous antibodies
|
|
ATE408012T1
(de)
|
1991-12-02 |
2008-09-15 |
Medical Res Council |
Herstellung von autoantikörpern auf phagenoberflächen ausgehend von antikörpersegmentbibliotheken
|
|
US5589174A
(en)
|
1992-09-17 |
1996-12-31 |
Takara Shuzo Co., Ltd. |
Anti-human influenza virus antibody
|
|
EP0621339B1
(en)
|
1992-09-17 |
2001-10-24 |
Takara Shuzo Co. Ltd. |
Immunogenic human influenza A virus haemagglutinin polypeptides
|
|
JP3037554B2
(ja)
|
1993-04-20 |
2000-04-24 |
寳酒造株式会社 |
免疫原性人工ポリペプチド
|
|
US6337070B1
(en)
|
1993-04-29 |
2002-01-08 |
Takara Shuzo Co., Ltd. |
Polypeptides for use in generating anti-human influenza virus antibodies
|
|
GB9221654D0
(en)
|
1992-10-15 |
1992-11-25 |
Scotgen Ltd |
Recombinant human anti-cytomegalovirus antibodies
|
|
WO1994016109A1
(en)
*
|
1993-01-15 |
1994-07-21 |
Whitehead Institute For Biomedical Research |
Membrane fusion events and means for altering same
|
|
WO1994017826A1
(en)
|
1993-02-01 |
1994-08-18 |
Smithkline Beecham Corporation |
Vaccinal polypeptides
|
|
US5573916A
(en)
*
|
1994-05-19 |
1996-11-12 |
Coretech, Inc. |
Immunogenic constructs comprising b-cell and t-cell epitopes on common carrier
|
|
US5622701A
(en)
|
1994-06-14 |
1997-04-22 |
Protein Design Labs, Inc. |
Cross-reacting monoclonal antibodies specific for E- and P-selectin
|
|
EP1978033A3
(en)
|
1995-04-27 |
2008-12-24 |
Amgen Fremont Inc. |
Human antibodies derived from immunized xenomice
|
|
WO1996034096A1
(en)
|
1995-04-28 |
1996-10-31 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
|
US5916771A
(en)
|
1996-10-11 |
1999-06-29 |
Abgenix, Inc. |
Production of a multimeric protein by cell fusion method
|
|
ATE549918T1
(de)
|
1996-12-03 |
2012-04-15 |
Amgen Fremont Inc |
Menschliche antikörper, die ausdrücklich menschliches tnf alpha binden
|
|
US6165476A
(en)
|
1997-07-10 |
2000-12-26 |
Beth Israel Deaconess Medical Center |
Fusion proteins with an immunoglobulin hinge region linker
|
|
ATE330015T1
(de)
|
1999-04-29 |
2006-07-15 |
Syngenta Ltd |
Herbizidresistente pflanzen
|
|
CA2383105C
(en)
*
|
1999-09-24 |
2010-01-26 |
Smithkline Beecham Biologicals S.A. |
Intranasal influenza virus vaccine
|
|
US7521220B2
(en)
|
1999-11-26 |
2009-04-21 |
Crucell Holland B.V. |
Production of vaccines
|
|
DK1317559T3
(da)
*
|
2000-04-28 |
2009-03-23 |
St Jude Childrens Res Hospital |
DNA-transfektionssystem til frembringelse af smitsom negativstrenget RNA-virus
|
|
US6632620B1
(en)
|
2000-06-22 |
2003-10-14 |
Andrew N. Makarovskiy |
Compositions for identification and isolation of stem cells
|
|
HUE027448T2
(en)
|
2002-02-13 |
2016-09-28 |
Wisconsin Alumni Res Found |
Signal to pack flu virus vectors
|
|
US20040091503A1
(en)
|
2002-08-20 |
2004-05-13 |
Genitrix, Llc |
Lectin compositions and methods for modulating an immune response to an antigen
|
|
CN1984999A
(zh)
|
2003-01-29 |
2007-06-20 |
纽约州立大学研究基金会 |
耐受诱导的靶向抗体产生
|
|
WO2004075829A2
(en)
*
|
2003-01-30 |
2004-09-10 |
Chiron Corporation |
Adjuvanted influenza vaccine
|
|
JP4368594B2
(ja)
|
2003-02-24 |
2009-11-18 |
株式会社インシリコサイエンス |
タンパク質構造予測装置、タンパク質構造予測方法、プログラム、および、記録媒体
|
|
KR20060035596A
(ko)
|
2003-05-05 |
2006-04-26 |
보이스 톰슨 인스터튜트 포 플랜트 리서치 |
외래유전자도입 식물로부터 유래된 면역보호성 조성물을제조하기 위한 벡터와 세포
|
|
US8592197B2
(en)
|
2003-07-11 |
2013-11-26 |
Novavax, Inc. |
Functional influenza virus-like particles (VLPs)
|
|
DK2261378T3
(da)
*
|
2003-11-04 |
2014-01-20 |
Univ Tulane |
Fremgangsmåde til hindring af virus:celle-fusion ved hæmning af funktionen af fusionsinitieringsregionen i RNA virus med klasse I membranfusogene kappeproteiner
|
|
ES2454266T3
(es)
*
|
2004-05-25 |
2014-04-10 |
Medimmune, Llc |
Variantes de la hemaglutinina y la neuraminidasa de influenza
|
|
WO2006104615A2
(en)
*
|
2005-02-24 |
2006-10-05 |
University Of Massachusetts |
Influenza nucleic acids, polypeptides, and uses thereof
|
|
US20070020238A1
(en)
|
2005-06-01 |
2007-01-25 |
David Baltimore |
Method of targeted gene delivery using viral vectors
|
|
JP4758148B2
(ja)
|
2005-06-14 |
2011-08-24 |
泰三 宇田 |
インフルエンザウイルスのヘマグルチニンに対する抗体酵素
|
|
PL1951299T3
(pl)
*
|
2005-11-04 |
2012-07-31 |
Novartis Ag |
Szczepionki przeciw grypie zawierające kombinacje adiuwantów cząsteczkowych i czynników wzmacniających immunogenność
|
|
HUE037464T2
(hu)
|
2005-12-02 |
2018-08-28 |
Icahn School Med Mount Sinai |
Nem-natív felületi fehérjéket prezentáló kiméra Newcastle disease vírusok és alkalmazásuk
|
|
US7914797B2
(en)
*
|
2005-12-06 |
2011-03-29 |
Yeda Research And Development Co. Ltd. At The Weizmann Institute Of Science |
Influenza vaccine
|
|
US10183986B2
(en)
*
|
2005-12-15 |
2019-01-22 |
Industrial Technology Research Institute |
Trimeric collagen scaffold antibodies
|
|
WO2007103322A2
(en)
|
2006-03-07 |
2007-09-13 |
Vaxinnate Corporation |
Compositions that include hemagglutinin, methods of making and methods of use thereof
|
|
CA2652452C
(en)
|
2006-05-15 |
2018-07-31 |
Sea Lane Biotechnologies, Llc |
Neutralizing antibodies to influenza viruses
|
|
US8148085B2
(en)
|
2006-05-15 |
2012-04-03 |
Sea Lane Biotechnologies, Llc |
Donor specific antibody libraries
|
|
US9511134B2
(en)
*
|
2006-05-18 |
2016-12-06 |
Epimmune Inc. |
Inducing immune responses to influenza virus using polypeptide and nucleic acid compositions
|
|
EP2035565A4
(en)
|
2006-06-30 |
2010-07-21 |
Novavax Inc |
METHODS OF ENHANCING THE INCORPORATION OF PROTEINS IN VIRUS-LIKE PARTICLES (VLPs)
|
|
BRPI0714495B8
(pt)
|
2006-07-21 |
2021-05-25 |
California Inst Of Techn |
lentivírus deficiente para replicação recombinante pseudotipado
|
|
US8192927B2
(en)
|
2006-09-07 |
2012-06-05 |
Crucell Holland B.V. |
Human bind molecules capable of neutralizing influenza virus h5n1 and uses thereof
|
|
ES2536401T3
(es)
|
2006-09-11 |
2015-05-25 |
Novartis Ag |
Fabricación de vacunas contra virus de la gripe sin usar huevos
|
|
US8603467B2
(en)
*
|
2007-06-15 |
2013-12-10 |
Xiamen University |
Monoclonal antibodies binding to avian influenza virus subtype H5 haemagglutinin and uses thereof
|
|
EP2014279A1
(en)
*
|
2007-06-22 |
2009-01-14 |
Pevion Biotech AG |
Virosomes comprising hemagglutinin derived from an influenza virus produced in a cell line, compositions, methods of manufacturing, use thereof
|
|
CA2615372A1
(en)
|
2007-07-13 |
2009-01-13 |
Marc-Andre D'aoust |
Influenza virus-like particles (vlps) comprising hemagglutinin
|
|
US20090092635A1
(en)
|
2007-08-17 |
2009-04-09 |
Wyeth |
Heterologous prime-boost immunization regimen
|
|
EP2200639B1
(en)
*
|
2007-09-24 |
2016-03-30 |
Government of the USA, as Represented by the Secretary, Department of Health and Human Services |
Immunostimulatory combinations of tlr3 ligands with tlr2 and tlr9 agonists and methods of use
|
|
FR2921387B1
(fr)
|
2007-09-26 |
2012-04-20 |
Sanofi Pasteur |
Procede de production du virus de la grippe
|
|
GB0810305D0
(en)
|
2008-06-05 |
2008-07-09 |
Novartis Ag |
Influenza vaccination
|
|
NZ587108A
(en)
|
2007-11-27 |
2013-04-26 |
Medicago Inc |
Recombinant influenza virus-like particles (vlps) produced in transgenic plants expressing hemagglutinin
|
|
CN101970483A
(zh)
|
2007-12-06 |
2011-02-09 |
达纳-法伯癌症研究公司 |
抗流感病毒抗体及其使用方法
|
|
ITTO20080204A1
(it)
|
2008-03-17 |
2009-09-18 |
Pomona Biotechnologies Llc |
Anticorpi monoclonali atti a reagire con una pluralita di sottotipi del virus influenzale a
|
|
CN102046656A
(zh)
|
2008-03-28 |
2011-05-04 |
航道生物技术有限责任公司 |
针对病毒抗原的中和性分子
|
|
GB0905570D0
(en)
|
2009-03-31 |
2009-05-13 |
Novartis Ag |
Combined vaccines
|
|
ES2524553T3
(es)
*
|
2008-06-17 |
2014-12-10 |
Apogenix Gmbh |
Receptores multiméricos de TNF
|
|
EP2300609B1
(en)
|
2008-06-25 |
2013-11-20 |
INSERM - Institut National de la Santé et de la Recherche Médicale |
Novel immunoadjuvant flagellin-based compounds and use thereof
|
|
WO2010003235A1
(en)
|
2008-07-08 |
2010-01-14 |
Medicago Inc. |
Soluble recombinant influenza antigens
|
|
WO2010117786A1
(en)
|
2009-03-30 |
2010-10-14 |
Mount Sinai School Of Medicine Of New York University |
Influenza virus vaccines and uses thereof
|
|
MY183517A
(en)
|
2009-05-11 |
2021-02-24 |
Janssen Vaccines & Prevention Bv |
Human binding molecules capable of neutralizing influenza virus h3n2 and uses thereof
|
|
JP5941841B2
(ja)
|
2009-05-26 |
2016-06-29 |
アイカーン スクール オブ メディシン アット マウント サイナイ |
周期的投与によって作製されたインフルエンザウイルスに対するモノクローナル抗体及びその使用
|
|
EP3228627A1
(en)
|
2009-06-24 |
2017-10-11 |
Medicago Inc. |
Chimeric influenza virus- like particles comprising hemagglutinin
|
|
US8828406B2
(en)
*
|
2009-07-30 |
2014-09-09 |
Icahn School Of Medicine At Mount Sinai |
Influenza viruses and uses thereof
|
|
JP5463107B2
(ja)
|
2009-09-14 |
2014-04-09 |
独立行政法人国立国際医療研究センター |
新型インフルエンザを特異的に鑑別するモノクローナル抗体とそれを利用した免疫検出試薬
|
|
JP2013060367A
(ja)
|
2010-01-15 |
2013-04-04 |
Osaka Univ |
抗インフルエンザ抗体及びインフルエンザ検出用デバイス
|
|
US8298820B2
(en)
*
|
2010-01-26 |
2012-10-30 |
The Trustees Of The University Of Pennsylvania |
Influenza nucleic acid molecules and vaccines made therefrom
|
|
AU2011217903B2
(en)
|
2010-02-18 |
2017-03-02 |
Mount Sinai School Of Medicine |
Vaccines for use in the prophylaxis and treatment of influenza virus disease
|
|
EA021977B1
(ru)
|
2010-03-08 |
2015-10-30 |
Селлтрион, Инк. |
Моноклональные антитела человека, полученные из в-клеток человека и обладающие нейтрализующей активностью против вирусов гриппа а
|
|
US9708373B2
(en)
|
2010-03-30 |
2017-07-18 |
Icahn School Of Medicine At Mount Sinai |
Influenza virus vaccine and uses thereof
|
|
WO2012009790A1
(en)
|
2010-07-22 |
2012-01-26 |
Schrader John W |
Cross-protective pathogen protection, methods and compositions thereof
|
|
WO2013043729A1
(en)
|
2011-09-20 |
2013-03-28 |
Mount Sinai School Of Medicine |
Influenza virus vaccines and uses thereof
|
|
EP3566714A1
(en)
|
2011-11-28 |
2019-11-13 |
Janssen Vaccines & Prevention B.V. |
Influenza virus vaccines and uses thereof
|
|
WO2014090865A1
(en)
|
2012-12-11 |
2014-06-19 |
Vib Vzw |
Anti-influenza antibody
|
|
EP2934581B1
(en)
|
2012-12-18 |
2022-09-14 |
Icahn School of Medicine at Mount Sinai |
Influenza virus vaccines and uses thereof
|